[New findings on Entamoeba histolytica].
D000562:Amebiasis / Q000188:drug therapy / Q000276:immunology; D000941:Antigens; D004586:Electrophoresis; D004748:Entamoeba histolytica / Q000145:classification / Q000201:enzymology / Q000276:immunology; D004917:Erythromycin / Q000627:therapeutic use; D005941:Glucokinase / Q000032:analysis; D005956:Glucose-6-Phosphate Isomerase / Q000032:analysis; D006801:Humans; D008291:Malate Dehydrogenase / Q000032:analysis; D008795:Metronidazole / Q000627:therapeutic use; D010118:Oxytetracycline / Q000627:therapeutic use; D010303:Paromomycin / Q000627:therapeutic use; D010733:Phosphoglucomutase / Q000032:analysis; D012882:Skin Tests
D000941:Antigens; D008795:Metronidazole; D010303:Paromomycin; D004917:Erythromycin; D008291:Malate Dehydrogenase; D005941:Glucokinase; D005956:Glucose-6-Phosphate Isomerase; D010733:Phosphoglucomutase; D010118:Oxytetracycline
Nuove acquisizioni su Entamoeba histolytica.